General Information of the Compound
| Compound ID |
CP0514015
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(4-chlorophenyl)-5-[4-(1,8-naphthyridin-2-yl)butyl]-1,3,4-oxadiazole
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H17ClN4O
|
||||||||||||||||||
| Molecular Weight |
364.836
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(cc1)-c1nnc(CCCCc2ccc3cccnc3n2)o1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H17ClN4O/c21-16-10-7-15(8-11-16)20-25-24-18(26-20)6-2-1-5-17-12-9-14-4-3-13-22-19(14)23-17/h3-4,7-13H,1-2,5-6H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
JCFJKQLQKRHRNS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound